drugset / Trial / NCT03691441

Comparative Effectiveness Trial of Transoral Head and Neck Surgery Followed by Adjuvant Radio(Chemo)Therapy Versus Primary Radiochemotherapy for Oropharyngeal Cancer

NCT03691441

RandomizedParallel-groupOpen-labelTreatment

Summary

Comparative Effectiveness Trial of Transoral Head and Neck Surgery followed by adjuvant Radio(chemo)therapy versus primary Radiochemotherapy for Oropharyngeal Cancer

Timeline

Start
2018-01-05
Primary completion
2024-05-05
Completion
2024-05-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 30 mg/m2 Intravenous
Subject Cisplatin Other / unclassified 40 mg/m2 Intravenous
Subject Cisplatin Other / unclassified 100 mg/m2 Intravenous
Subject Mitomycin C Other / unclassified 10 mg/m2
Subject fluorouracil Small molecule 600 mg/m2 Intravenous

Indications